Relugolix as a promising novel oral GnRH antagonist for prostate cancer treatment

Asian J Androl. 2021 May-Jun;23(3):229-230. doi: 10.4103/aja.aja_77_20.

Authors

Jialu Lv¹, Jianqing Lin²

Affiliations

¹ Ningbo University Medical School, Ningbo 315211, China.
² The George Washington University School of Medicine and Health Sciences, Washington, DC 20037, USA.

No abstract available

MeSH terms

Gonadotropin-Releasing Hormone / antagonists & inhibitors*
Gonadotropin-Releasing Hormone / therapeutic use
Humans
Male
Phenylurea Compounds / antagonists & inhibitors*
Phenylurea Compounds / therapeutic use
Prostatic Neoplasms / drug therapy*
Pyrimidinones / antagonists & inhibitors*
Pyrimidinones / therapeutic use

Substances

Phenylurea Compounds
Pyrimidinones
relugolix
Gonadotropin-Releasing Hormone